BVF INC/IL - POINT BIOPHARMA GLOBAL INC ownership

Quarter-by-quarter ownership
BVF INC/IL ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$70,460,199
-26.4%
10,563,7480.0%1.90%
-28.8%
Q2 2023$95,707,557
+24.6%
10,563,7480.0%2.67%
-5.0%
Q1 2023$76,798,448
+14.8%
10,563,748
+15.1%
2.81%
-0.6%
Q4 2022$66,905,783
+54.8%
9,177,748
+64.2%
2.82%
+58.2%
Q3 2022$43,211,000
+88.4%
5,590,048
+66.0%
1.78%
+61.1%
Q2 2022$22,935,000
-14.6%
3,367,8260.0%1.11%
+3.2%
Q1 2022$26,842,000
+64.1%
3,367,826
+15.3%
1.07%
+80.8%
Q4 2021$16,355,000
-23.3%
2,920,526
+5.3%
0.59%
-28.6%
Q3 2021$21,318,0002,772,2260.83%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q4 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,909,960$19,409,4333.54%
JOHNSON & JOHNSON 1,000,000$6,670,0002.46%
BVF INC/IL 10,563,748$70,460,1991.90%
SPHERA FUNDS MANAGEMENT LTD. 952,642$6,354,1221.16%
Boxer Capital, LLC 2,500,000$16,675,0000.89%
Pier Capital, LLC 732,936$4,888,6830.79%
Deep Track Capital, LP 2,781,565$18,553,0390.72%
PFM Health Sciences, LP 1,613,516$10,762,1520.51%
Eagle Health Investments LP 306,142$2,041,9670.45%
Onex Canada Asset Management Inc. 772,905$5,155,2760.40%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders